Insider Trading - Myers Scott Dunseth

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Myers Scott Dunseth

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-01-27
Purchase
2017-01-31
4:55 pm
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
20,500 $3.758 $77,039 38,416
(Direct)
View
2017-03-20
Purchase
2017-03-21
8:09 pm
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
1,000 $3.9271 $3,927 39,416
(Direct)
View
2017-03-31
Purchase
2017-04-04
5:39 pm
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
2,000 $4.1143 $8,229 41,416
(Direct)
View
2017-05-12
Purchase
2017-05-16
5:43 pm
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
2,800 $3.997 $11,192 44,216
(Direct)
View
2017-08-11
Purchase
2017-08-14
5:12 pm
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
5,500 $3.735 $20,543 49,716
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-01-11
Option Award
2017-01-13
7:48 pm
N/A
2027-01-11
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
232,000 $0 232,000
(Direct)
View
2017-09-18
Option Award
2017-09-20
9:07 pm
N/A
2027-09-18
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
75,500 $0 75,500
(Direct)
View
2017-11-10
Option Award
2017-11-13
8:00 pm
N/A
2021-09-18
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
6,300 $0 6,300
(Direct)
View
2018-01-11
Exercise
2018-01-16
5:26 pm
N/A
2027-01-11
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
10,500 $0 88,287
(Direct)
View
2018-01-11
Tax Withholding
2018-01-16
5:26 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
3,429 $3.92 88,287
(Direct)
View
2018-02-01
Option Award
2018-02-02
5:54 pm
N/A
2022-02-01
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
250,000 $0 250,000
(Direct)
View
2018-03-09
Disposition
2018-03-13
6:07 pm
N/A
2026-04-04
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
1,038,610 $0 0
(Direct)
View
2018-03-09
Equity Swap
2018-03-13
6:07 pm
N/A
N/A
Cascadian Therapeutics Inc. CASC Myers Scott Dunseth
CEO
56,787 $0 0
(Direct)
View
2019-06-03
Option Award
2019-06-05
5:30 pm
N/A
2029-06-02
Harpoon Therapeutics Inc. HARP Myers Scott Dunseth
Director
10,167 $0 10,167
(Direct)
View
2019-06-14
Option Award
2019-06-18
4:21 pm
N/A
2029-06-13
SELECTA BIOSCIENCES INC SELB Myers Scott Dunseth
Director
20,000 $0 20,000
(Direct)
View
2019-08-20
Option Award
2019-08-20
4:32 pm
N/A
N/A
SELECTA BIOSCIENCES INC SELB Myers Scott Dunseth
Director
41,436 $1.81 41,436
(Direct)
View
2019-12-23
Option Award
2019-12-26
5:29 pm
2019-12-23
2024-12-23
SELECTA BIOSCIENCES INC SELB Myers Scott Dunseth
Director
19,704 $0.125 100,549
(Direct)
View
2019-12-23
Option Award
2019-12-26
5:29 pm
N/A
N/A
SELECTA BIOSCIENCES INC SELB Myers Scott Dunseth
Director
39,409 $1.46 100,549
(Direct)
View
2020-04-28
Option Award
2020-04-30
5:02 pm
N/A
2030-04-28
AMAG PHARMACEUTICALS Inc AMAG Myers Scott Dunseth
CEO
1,000,000 $0 1,000,000
(Direct)
View
2020-05-28
Option Award
2020-06-01
9:50 pm
N/A
2030-05-27
Harpoon Therapeutics Inc. HARP Myers Scott Dunseth
Director
10,167 $0 10,167
(Direct)
View
2020-06-19
Option Award
2020-06-23
4:47 pm
N/A
2030-06-18
SELECTA BIOSCIENCES INC SELB Myers Scott Dunseth
Director
20,000 $0 20,000
(Direct)
View
2020-11-16
Disposition
2020-11-17
3:42 pm
N/A
N/A
AMAG PHARMACEUTICALS Inc AMAG Myers Scott Dunseth
CEO
1,000,000 $0 0
(Direct)
View
2021-03-30
Option Award
2021-04-01
6:31 pm
N/A
2031-03-29
SELECTA BIOSCIENCES INC SELB Myers Scott Dunseth
Director
40,000 $0 40,000
(Direct)
View
2021-05-03
Option Award
2021-05-05
4:16 pm
N/A
2031-05-03
Trillium Therapeutics Inc. TRIL Myers Scott Dunseth
Director
67,000 $0 67,000
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:56 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP Myers Scott Dunseth
Director
10,167 $0 10,167
(Direct)
View
2021-05-04(A)
Option Award
2021-05-14
8:03 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP Myers Scott Dunseth
Director
10,167 $0 10,167
(Direct)
View
2021-10-19
Option Award
2021-10-21
5:04 pm
N/A
N/A
DYNAVAX TECHNOLOGIES CORP DVAX Myers Scott Dunseth
Director
55,714 $0 55,714
(Direct)
View
2021-10-25
Option Award
2021-10-26
4:22 pm
N/A
2031-10-25
Harpoon Therapeutics Inc. HARP Myers Scott Dunseth
Director
10,167 $0 10,167
(Direct)
View
2021-11-17
Disposition
2021-11-19
1:33 pm
N/A
2031-05-03
Trillium Therapeutics Inc. TRIL Myers Scott Dunseth
Director
67,000 $0 0
(Direct)
View
(A) Indicate amendment filing.